NarcX

BE PART OF THE SOLUTION

Print
Follow Claim My Business
Security Type
Common Stock
Categories
Retail, Technology
Min Investment
$250
Location
NEW STANTON, PA
Offering Date
December 17, 2021
Expected Close Date
April 30, 2022
Target Raise
$10.00K-$1.07M
No. Investors
66
Security Price
$1
Valuation
$35,000,000
Website
narcx.com
Number of Employees
5
Cash
$32,621
Revenue
$235,025
Short Term Debt
$41,331
Cost of Goods
$131,482
Long Term Debt
$615,591
Net Income
$-197,772

Company Description

NarcX® provides a practical, effective and affordable solution to address the problem of drug disposal in the fight against the opioid crisis. We created an environmentally safe liquid solution that renders controlled substances such as pills, tablets, or liquids immediately non-divertible and ultimately non-retrievable.

Key Deal Facts

The drug disposal industry is set to reach a value of $2 billion by 2025, and the push for onsite disposal solutions is growing.
Our proprietary, patent-pending solution renders non-retrievable prescription drugs and illicit drugs and addictive substances for eco-friendly disposal.
Our team is composed of experienced professionals and passionate supporters committed to ending the opioid crisis.

Management Team / Advisory Board Bios

Jordan Erskine
Chief Executive Officer
Jordan Erskine is a highly motivated entrepreneurial individual who has co-founded many successful businesses. Jordan has over 16 years in the personal care/skincare industry. Jordan currently serves as President for the award-winning contract manufacturer Dynamic Blending.
Jordan has spent his entire career in the manufacturing and R&D world. Jordan started his career at a large contract manufacturing facility, Wasatch Product Development, in Draper Utah. At Wasatch Product Development he wore many hats in R&D, manufacturing, formulations, etc. He spent many years in R&D developing new and innovative personal care/skincare products. Jordan then moved on to a large dental manufacturing firm named Ultradent Products, Inc. Here, Jordan formulated and provided technical formulations assistance for two large Fortune 500 company accounts, Glaxo Smith-Kline and Colgate-Palmolive.
Jordan is passionate about helping to solve or mitigate the opioid epidemic. Jordan, and the rest of the dedicated NarcX® team, is excited to bring the only on-site medication disposal method to the market.
Jordan holds an MBA in International Business from Northeastern University.


David Schiller
Chief Compliance Officer
David Schiller is a former DEA Assistant Special Agent in Charge with over 30 years of experience with the United States Drug Enforcement Administration (DEA). Beginning with his hiring as a Special Agent in 1987, he was involved in investigating some of the largest criminal drug trafficking organizations throughout the world. After serving as the Executive Assistant to the Assistant Administrator in Arlington, Virginia, Schiller was reassigned in 2009 as the Assistant Special Agent in Charge (ASAC) for the Denver Field Division. He was subsequently assigned complete supervisory oversight for the DEA’s Diversion Program. This included supervisory oversight of all of the Tactical Diversion Squads and Diversion Groups in Colorado, Utah, Montana, and Wyoming. In this capacity, Schiller led the investigation of all criminal, administrative, and civil cases affecting every one of DEA’s Registrants, including manufacturers, distributors, pharmacies, hospitals, narcotic treatment providers, and doctors.
In 2015, Schiller was selected to be the Vice-Chair of DEA’s Diversion Field Advisory Committee (DFAC), with ultimate responsibility for coordinating all diversion-related matters for every one of DEA’s 21 Field Divisions in the United States. He ended his distinguished career by finalizing the largest administrative and civil settlement against a DEA Registrant in history—the McKesson Corporation. He retired from DEA in August 2017. Schiller’s vast experience and background were invaluable in co-founding NarcX® and contributing to the development of its game-changing products.


Christian Kasteler
Director of Research & Development
Christian Kasteler is a Chemical Engineer with an emphasis in Bio-Chemical Engineering, working for over 15 years in the pharmaceutical industry. Christian believes that science and engineering can directly improve lives and enjoys taking an idea from concept to production. When tasked with developing a new product, he takes pride in delivering tangible, effective results that exceed expectations.
Christian has spent his career developing and producing pharmaceuticals, cosmetics, and medical devices. Christian is naturally curious and thrives on focusing his sharp, scientific mind on solving problems and creating effective solutions. Throughout his career, he has refined the processing of biodegradable polymers for esophageal chemotherapy treatment; developed innovative oral care products presently used within the dental industry; and worked as the Director of R&D for a compounding pharmacy. Christian currently serves as the Director of Research and Development at Dynamic Blending where he continues to generate positive results by developing a variety of drug, device, and cosmetic products. Christian’s experience was invaluable in the development of the NarcX® solution. When approached with the idea of creating a drug disposal product, he relied on his scientific expertise to develop the only DEA-compliant medication destruction method available today. Christian is proud to be a part of the NarcX® team. Christian holds a B.S. degree in Chemical Engineering from the University of Utah.


Gavin Collier
Chairman of the Board
Gavin began his education at Brigham Young University where he earned his Bachelor of Science in Biology. His major included emphasis in chemistry as well as Molecular, Micro, and Evolutionary Biology. With his scientific knowledge, Gavin worked in chemical formulations Research and Development for several years. Thereafter, Gavin continued his education and attended Law School where he earned his Doctor of Jurisprudence.
Gavin is a licensed attorney in the State of Utah and practiced in Federal and State Court. Gavin has demonstrated again and again his skill as a trial attorney and skilled negotiator. Gavin is aggressive, highly organized, and extremely detailed in all that he does. Gavin is also an entrepreneur and has co-founded Dynamic Blending Specialists, NarcX® as well as many other successful businesses.
Languages: English & Spanish


Jim Carroll
Board of Advisors
Jim (James) Carroll, principal and co-founder of DC Consulting LLC, a strategy and management consulting firm serving public, private, and non-profit clients offering services in the area of healthcare, pharmaceuticals, drug policy, drug use prevention, law enforcement, and communities.
Carroll previously served as the Director of the White House Office of National Drug Control Policy (ONDCP) from Feb 2019 to Jan 2021. Acting Director and Deputy Director of ONDCP from Feb 2018 to Jan 2019. Under the leadership of Director Carroll, the United States saw its first annual decrease in overdose deaths for the first time in 30 years; the number of drugs seized by law enforcement at our Nation’s borders stood at all-time highs; and record Federal grants were awarded in support of drug interdiction and public health programs.
In his role as “Drug Czar,” Carroll served as the principal advisor to the Administration on drug policy and managed a passionate staff of approximately 100 professionals. He oversaw a budget of more than $35 billion and successfully coordinated the activities and related funding of sixteen Federal government agencies and departments to reduce the supply of and demand for illicit substances.
Under the Trump Administration, Carroll also served as Assistant to the President and Deputy Chief of Staff at the White House, General Counsel of the Office of Management and Budget, and as Deputy Assistant and Senior Counsel to the President.
Under the George W. Bush Administration, served as Special Assistant and Associate Counsel to the President at the White House, Deputy General Counsel and Acting General Counsel at the U.S. Department of the Treasury, and as an attorney at the U.S. Department of Justice. 
Carroll also served as a state prosecutor in Virginia after earning his bachelor’s degree from the University of Virginia and his J.D. from the George Mason University School of Law.


Juan Riboldi
Strategic Advisor
Juan serves as NarcX Strategic Advisor assisting the executive team on strategic decisions to deliver critical results, including capital strategies, capitalization initiatives, and investor relations.
Juan brings extensive experience working across the US and internationally with well-known Fortune 50 corporations and fast-growing private enterprises.
With a strong entrepreneurial background, Juan assists NarcX executives to identify, qualify, launch, and onboard strategic partnerships.
Juan has a Master's Degree in Business Management with an emphasis in Strategy, Organization, Leadership, and Mergers & Acquisitions from BYU, Harvard School of Business, and Wharton Business School.
Amount Raised : $102,501
Reveal the Score by Voting
_
0
Business Idea
Business Traction
Management Team
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments